Interleukin-6 as an enhancer of anti-angiogenic therapy for ovarian clear cell carcinoma

Ovarian clear cell carcinoma (OCCC) is a subtype of epithelial ovarian cancer (EOC) that is associated with elevated interleukin-6 (IL-6) expression, resistance to chemotherapy, and increased mortality. Although bevacizumab (Bev) is a widely used anti-angiogenic agent for EOC, the efficacy of Bev an...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Sci Rep
Main Authors: Seki, Toshiyuki, Yanaihara, Nozomu, Shapiro, Jason Solomon, Saito, Misato, Tabata, Junya, Yokomizo, Ryo, Noguchi, Daito, Kuroda, Takafumi, Kawabata, Ayako, Suzuki, Jiro, Takahashi, Kazuaki, Matsuzawa, Haruka, Miyake, Misayo, Takenaka, Masataka, Iida, Yasushi, Yanagida, Satoshi, Okamoto, Aikou
פורמט: Artigo
שפה:Inglês
יצא לאור: Nature Publishing Group UK 2021
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC8032732/
https://ncbi.nlm.nih.gov/pubmed/33833265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-86913-9
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים